Rohini Patil; Kamal Shah; Deepak Bhosle
Abstract
Background: Evaluation of the impact of stress on glycaemic control in hospitalized type-2 diabetes (T2DM) patients with coronavirus disease (COVID-19).Methods: In this retrospective study conducted at a single centre in Maharashtra from May to July 2020 on hospitalized COVID-19 patients with T2DM who ...
Read More
Background: Evaluation of the impact of stress on glycaemic control in hospitalized type-2 diabetes (T2DM) patients with coronavirus disease (COVID-19).Methods: In this retrospective study conducted at a single centre in Maharashtra from May to July 2020 on hospitalized COVID-19 patients with T2DM who reported having stress of pandemic; they were selected using purposive sampling. DASS-12 stress sub-scale was used to estimate the severity of their stress. Fasting blood glucose (FBG) and post-prandial blood glucose (PPBG) before admission and at the time of discharge were compared.Results: One hundred and ninety-nine patients (mean age 54 years; 61.30% females) were included. Mean±SD FBG before admission was 168.4±30.6 mg/dl which increased to 195.9±28.8 mg/dl at the time of discharge (P<0.001). Also, Mean±SD PPBG before admission was 312±62.3 mg/dl which increased to 351.6±61.9 mg/dl (P<0.001). A total of 73 (36.7%) participants had perceived stress. Moderate and severe/extremely severe stress was found in 44 (27.1%) and 19 (9.6%) patients, respectively. A significant difference was observed in the mean FBG before and during discharge in patients who had no stress and those with moderate stress (P<0.001). There was no difference in FBG in patients with severe/extremely severe stress (P=0.43). Similar observations were seen for PPBG (no stress P<0.001; moderate stress P<0.001; severe/extremely severe stress P=0.06).Conclusion: There was a rise in the glucose level in T2DM patients discharged after COVID-19 treatment. The increase was significant in T2DM without stress and those with moderate stress. In addition to traditional treatment, measures for psychological stress control should also be taken for such patients.
Mohsen Poursadeqiyan; Nayyereh Kasiri; Behzad Khedri; Zahra Ghalichi Zaveh; Amin Babaei Pouya; Somayeh Barzanouni; milad Abbasi; Maryam Feiz Arefi; Farahnaz Khajehnasiri; Naser Dehghan
Abstract
Background: People’s participation in more efficient control of the disease and public awareness about the risk of COVID-19 affect their preventive behavior. This study examines the level of fear of COVID-19 infection in Iranian society after returning to social activities and business reopening. ...
Read More
Background: People’s participation in more efficient control of the disease and public awareness about the risk of COVID-19 affect their preventive behavior. This study examines the level of fear of COVID-19 infection in Iranian society after returning to social activities and business reopening. Methods: This Cross-Sectional study consisted of urban dwellers in Iran, and the data gathering tool was a researcher-designed questionnaire. To design the instrument, the authors interviewed experts and ordinary people to determine the key questions . Then, the questions were modified and finalized based on the experts’ feedback and a reexamination by the experts after two weeks. An online version of the questionnaire was disseminated using social networks. 168 people were included in the study by the available sampling method. Data were analyzed through descriptive statistics methods. Quantitative data as mean and standard deviation were reported, and the qualitative data were reported as numbers. Chi-square test and Spearman correlation coefficient were used to examine the relationship between questions related to COVID-19 infection fear and demographic variables. Data analyses were done in SPSS 20. Results: The study was carried out on 168 participants, and 78 of them were employees of different offices. The participants believed that among the ways of spreading the disease, kissing and hugging (n=142, 84.5%), shaking hands (n=127, 75.6%), contact with the saliva of an infected person (n=116, 69.0%), and spread through the air (n=60, 35.7%) had the highest frequencies. Conclusion: Fear of COVID-19 infection in the participants was at moderate and above moderate levels. The participants also hoped that the vaccine would be found and made available to the public. Policy-makers in the health sector can use the results.
Ali Kamkar; Mahmoud Golzary; Noor Ali Farrokhi; Shapur Aghaee; Mohammad Fararouei
Volume 3, Issue 2 , April 2015, , Pages 76-82
Abstract
Backgrounds: Anxiety and depression are found to be the major contributors to irritable bowel syndrome (IBS). The present study aimed to measure the effect of a specifically designed cognitive behavioural therapy (CBT) program on the severity of the symptoms and quality of life of patients with chronic ...
Read More
Backgrounds: Anxiety and depression are found to be the major contributors to irritable bowel syndrome (IBS). The present study aimed to measure the effect of a specifically designed cognitive behavioural therapy (CBT) program on the severity of the symptoms and quality of life of patients with chronic IBS, and also define whether anxiety and depression in patients with IBS at baseline affect their response to CBT. Methods: The participants were randomly allocated to conventional treatment only (n=25, control) or CBT plus conventional treatment (n=25, intervention) group. The intervention group attended an eight session group stress management training course conducted by a psychologist in a meeting room at a gastrointestinal clinic at Yasuj University of Medical Sciences. Pre- and post-interventions and 3-month follow-up visits were scheduled and conducted by an experienced healthcare worker to measure the primary outcomes and levels of depression and anxiety in the patients. The study was conducted on 2011. Results: The Raw Group Difference (RGD) and Standardised Mean Differences (SMD) for the post-treatment scores of the intervention group, when compared with those of the control group, indicated a considerable improvement in the severity of IBS symptoms (RGD=−10.48, SMD=−1.23), anxiety (RGD=−9.90, SMD=−0.725), d epression ( RGD=−9.57, SMD=−0.785) a nd patient’s quality of life (MD=−16.81, SMD=−0.469). No association (and interaction with CBT) was found between anxiety/depression at baseline and post-treatment or follow-up scores of the outcomes. Conclusion: Although CBT improved anxiety, depression, severity of IBS and quality of life of patients with IBS, its effect was independent of the initial level of anxiety and depression of the patients. Trial registration number: IRCT201102195868N1